Osivax
Develops universal vaccines for influenza and other infectious diseases using an oligoDOM nanoparticle platform
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-30
About Osivax
Osivax develops vaccines using its oligoDOM self-assembling nanoparticle platform, designed to stimulate T-cell responses. Its vaccine programs combine this approach with antibody-based vaccines to target influenza and other infectious diseases.
The company is based in Paris and was founded in Lyon in 2017. Its lead candidate, OVX836, has reached Phase 2b clinical development; it also has other candidates in clinical development and a CMC project coordinator opening.
Product: Vaccine candidates and an oligoDOM nanoparticle technology platform for developing vaccines against infectious diseases.
Jobs at Osivax (1)
Osivax is hiring for one role in product.
Coordinateur(trice) de projet(s) CMC
New on Evolc
Leadership
- Alexandre Le Vert · Executive Chairman & Co-FounderSource: company website
- Delphine Guyon-Gellin · Chief Business Officer & Chief Operating OfficerSource: company website
- Florence Nicolas · Chief Scientific Officer & Co-FounderSource: company website
More biotech & pharma companies
Oz Biosciences
Transfection reagents, mRNA and lipid nanoparticle delivery systems for life science researchers and pharma, based in MarseilleNew on EvolcPanpharma
Develops, manufactures and distributes injectable medicines for healthcare establishments in more than 100 countriesNew on EvolcPhysiogenex
Preclinical drug testing and research services for pharmaceutical, biotechnologyNew on EvolcPK Med
Develops injectable biodegradable micro-implants for local drug delivery in rheumatology and hematologyNew on EvolcPoietis
Laser-assisted bioprinting systems for research laboratories and clinical tissue manufacturersNew on EvolcPromise Proteomics
Mass spectrometry protein and monoclonal antibody quantification products for clinical and bioanalytical laboratoriesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- PHP
- WordPress
- jQuery
